Macquarie Group LTD Glaukos Corp Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Glaukos Corp stock. As of the latest transaction made, Macquarie Group LTD holds 37,708 shares of GKOS stock, worth $5.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

37,708

Previous 55,270 31.77%

Holding current value

$5.69 Million

Previous $6.54 Million 24.9%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $2 Million - $2.38 Million	-17,562 Reduced 31.77%	37,708 $4.91 Million
Q2 2024 Aug 09, 2024	SELL	$89.48 - $118.35 $189,697 - $250,902	-2,120 Reduced 3.69%	55,270 $6.54 Million
Q1 2024 May 14, 2024	SELL	$76.4 - $96.33 $107,036 - $134,958	-1,401 Reduced 2.38%	57,390 $5.41 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $3.3 Million - $4.72 Million	-55,421 Reduced 48.52%	58,791 $4.67 Million
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $2.81 Million - $3.21 Million	40,532 Added 55.01%	114,212 $8.59 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $1.92 Million - $3 Million	42,169 Added 133.82%	73,680 $5.25 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $396,938 - $474,734	9,046 Added 40.27%	31,511 $1.58 Million
Q4 2022 Feb 21, 2023	BUY	$40.82 - $57.75 $900,244 - $1.27 Million	22,054 Added 5365.94%	22,465 $981,000
Q3 2022 Nov 14, 2022	SELL	$46.84 - $58.49 $9,602 - $11,990	-205 Reduced 33.28%	411 $70,000
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $52.4 Million - $93.1 Million	-1,104,791 Reduced 99.94%	616 $30,000
Q2 2021 Aug 13, 2021	BUY	$73.06 - $97.7 $80.7 Million - $108 Million	1,104,242 Added 94784.72%	1,105,407 $93.8 Million
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $25,213 - $34,876	-358 Reduced 23.51%	1,165 $98,000
Q2 2020 Aug 11, 2020	SELL	$28.78 - $46.83 $1.07 Million - $1.74 Million	-37,214 Reduced 96.07%	1,523 $59,000
Q1 2020 May 15, 2020	SELL	$25.53 - $70.14 $55,757 - $153,185	-2,184 Reduced 5.34%	38,737 $1.2 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $491,304 - $595,223	9,068 Added 28.47%	40,921 $2.23 Million
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $609,056 - $872,412	10,397 Added 48.46%	31,853 $1.99 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $177,861 - $220,151	2,797 Added 14.99%	21,456 $1.62 Million
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $168,236 - $266,990	-3,315 Reduced 15.09%	18,659 $1.46 Million
Q4 2018 Feb 15, 2019	BUY	$52.18 - $67.93 $169,793 - $221,044	3,254 Added 17.38%	21,974 $1.24 Million
Q3 2018 Nov 15, 2018	SELL	$38.13 - $68.37 $1.06 Million - $1.9 Million	-27,728 Reduced 59.7%	18,720 $1.22 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $17,069 - $27,507	618 Added 1.35%	46,448 $1.89 Million
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $122,435 - $162,150	-4,700 Reduced 9.3%	45,830 $1.41 Million
Q4 2017 Feb 15, 2018	BUY	$24.5 - $36.01 $312,375 - $459,127	12,750 Added 33.75%	50,530 $1.3 Million
Q3 2017 Nov 08, 2017	BUY	$31.26 - $42.03 $1.18 Million - $1.59 Million	37,780	37,780 $1.25 Million

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Glaukos Corp Transaction History